“polycystic ovary syndrome”的搜索结果，显示 351-360 项，共有 7605 项
Discontinuation of pirtobrutinib and venetoclax based on minimal residual disease (MRD) results is also investigational. However, the FDA has allowed the ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... ovarian cancer, (7) advanced, ...
A Study to Evaluate Regulation of the Metabolism of T-Cells by the Tumor Microenvironment in Ovarian Cancer Metastasis ... disease becomes tumor permissive. A ...
Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...
一份馈赠，无穷力量——今天就来伸出援手！ ... 您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。
... disease, with either carcinoma in situ with or without Ta/T1 disease. ... disease and factors that may determine disease progression and treatment response.
... Ovarian remnant syndrome, Peritoneal cancer, Gynecologic cancer. 显示更多擅长领域 针对Jamie N. Bakkum-Gamez, M.D.. Bill Cliby, M.D..
Chronic kidney disease, Kidney stone, High blood pressure, Polycystic kidney disease, Acute kidney inury, Focal segment...al glomerulosclerosis, Alport syndrome.
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。